For help on how to get the results you want, see our search tips.
89 results
Medicine
Maximum residue limits Remove Maximum residue limits filter
Referrals Remove Referrals filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
Referral safety status
Yes Remove Yes filter
-
List item
Referral: Modafinil
modafinil, associated names: Modasomil, Modiodal, Provigil, Vigil, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2010, EC decision date: 27/01/2011, Last updated: 26/04/2011 -
List item
Referral: Octagam
human normal immunoglobulin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 30/05/2011, Last updated: 26/04/2011 -
List item
Referral: Dextropropoxyphene
dextropropoxyphene, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 14/06/2010, Last updated: 07/04/2011 -
List item
Referral: Sibutramine
sibutramine, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 21/01/2010, EC decision date: 06/08/2010, Last updated: 09/03/2011 -
List item
Referral: Gadolinium-containing contrast agents
gadodiamide, gadopentetic acid, gadobenic acid, gadoxetic acid, gadoteridol, gadobutrol, gadoteric acid, associated names: Omniscan, Magnevist, Magnegita, Gado-MRT ratiopharm, Primovist, MultiHance, Dotarem, ProHance, Gadovist, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, Last updated: 06/12/2010 -
List item
Referral: Methylphenidate
methylphenidate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/01/2009, EC decision date: 27/05/2009, Last updated: 22/09/2010 -
List item
Referral: Etoricoxib
etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 21/11/2008 -
List item
Referral: Norfloxacin
norfloxacin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 19/11/2008, Last updated: 24/07/2008 -
List item
Referral: Moxifloxacin
moxifloxacin, associated names: Avalox, Avelox, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 24/10/2008, Last updated: 24/07/2008 -
List item
Referral: Ergot-derived dopamine agonists
bromocriptine, cabergoline, dihydroergocryptine, lisuride, pergolide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 26/06/2008 -
List item
Referral: Piroxicam
piroxicam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 07/09/2007, Last updated: 31/01/2008 -
List item
Referral: Agreal
veralipride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 01/10/2007, Last updated: 07/01/2008 -
List item
Referral: Lumiracoxib
lumiracoxib, associated names: Prexige, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 13/12/2007, Last updated: 14/12/2007 -
List item
Referral: Aprotinin
aprotinin, associated names: Trasylol, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/11/2007, EC decision date: 15/02/2008, Last updated: 22/11/2007 -
List item
Referral: Carisoprodol
carisoprodol, associated names: Somadril, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/11/2007, EC decision date: 05/02/2008, Last updated: 16/11/2007 -
List item
Referral: Clobutinol
clobutinol, associated names: Silomat, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 18/10/2007, EC decision date: 30/11/2007, Last updated: 19/10/2007 -
List item
Referral: Bicalutamide 150 mg
bicalutamide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/05/2007, EC decision date: 03/09/2007, Last updated: 03/10/2007 -
List item
Referral: Nimesulide
nimesulide, associated names: Aulin, Nimed, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 20/09/2007, EC decision date: 16/10/2009, Last updated: 21/09/2007 -
List item
Referral: Elidel
pimecrolimus, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/03/2006, Last updated: 29/08/2006 -
List item
Referral: Celecoxib
celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005 -
List item
Referral: Etoricoxib
etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005 -
List item
Referral: Lumiracoxib
lumiracoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005 -
List item
Referral: Paroxetine
paroxetine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 09/12/2004, EC decision date: 29/03/2005, Last updated: 22/11/2005 -
List item
Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005 -
List item
Referral: Loratadine and pseudoephedrine
loratadine, pseudoephedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 14/07/2004